FDA Inspection
Terumo BCT LtdTerumo BCT Ltd – FDA Inspection, Jun 26, 2026
Record Details
This FDA Inspection record concerns Terumo BCT Ltd, with an inspection on June 26, 2026, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · d3d69354-9681-4ae4-9a29-2fe8f3cde9fd
Inspection Facts
- Inspection number
- 1323646
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 211.160(a)Deviations from laboratory control requirements
- 21 CFR 211.194(a)(5)Calculations performed are in the records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Terumo BCT Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 19, 2023 | VAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| February 11, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 28, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Terumo BCT Ltd
- FDA Inspection 1195522 - 2023-01-19
- FDA Inspection 1207405 - 2022-02-11
- FDA Inspection 1115666 - 2019-04-11
- FDA Inspection 973196 - 2016-04-28
- FDA Inspection 873451 - 2014-03-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.